Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Attributions and self-efficacy for physical activity in multiple sclerosis.
Involvement of CD8(+) T Cells in Multiple Sclerosis.
Does the preclinical evidence for functional remyelination following engraftment into the injured spinal cord support progression to clinical trials?
Antigen-stimulated rosette formation by T lymphocytes in experimental allergic encephalomyelitis.
Modeling cognition and disease using human glial chimeric mice.
Assessment of Dysmyelination with RAFFn MRI: Application to Murine MPS I.
Ninjurin1 deficiency attenuates susceptibility of experimental autoimmune encephalomyelitis in mice.
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.
Cardiovascular effects of fingolimod: Relevance, detection and approach.
Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?
Vestibular and ocular motor function prior to and after therapeutic apheresis with small plasmafilter in multiple sclerosis.
Activation of endogenous neural stem cells for multiple sclerosis therapy.
Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments.
Guillain Barré Syndrome in a multiple myeloma patient after the first course of bortezomib therapy: A case report.
TGF-beta1 regulates human brain pericyte inflammatory processes involved in neurovasculature function.
Visual outcomes in pediatric optic neuritis.
Use of complementary and alternative medicine in patients with cancer or multiple sclerosis: possible public health implications.
Involvement of membrane skeletal molecules in the Schmidt-Lanterman incisure in Schwann cells.
Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial.
Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.
Efficacy of infliximab in neuro-Behçet's disease presenting with isolated longitudinally extensive transverse myelitis.
A guide to treating gait impairment with prolonged-release fampridine (Fampyra(®)) in patients with multiple sclerosis.
[Axonal Regeneration-related Molecules as Biomarkers for Multiple Sclerosis].
Functional course of Progressive Multifocal Leukoencephalopathy.
Similar barriers and facilitators to physical activity across different clinical groups experiencing lower limb spasticity.
Pages
« first
‹ previous
…
640
641
642
643
644
645
646
647
648
…
next ›
last »